Efficacy of simulated cefditoren versus amoxicillin-clavulanate free concentrations in countering intrastrain ftsI gene diffusion in Haemophilus influenzae

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 6, 2011, Pages 2788-2794

  González, Natalia ^a   Aguilar, Lorenzo ^a   Sevillano, David ^a   Giménez, Maria Jose ^a   Alou, Luis ^a   Cafini, Fabio ^a   Torrico, Martha ^a   López, Ana Maria ^a   Coronel, Pilar ^b   Prieto, Jose ^a  

^a SCHOOL OF MEDICINE   (Spain)

^b Tedec Meiji Farma SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFDITOREN; CEFUROXIME;

ANTIBIOTIC RESISTANCE; AREA UNDER THE CURVE; ARTICLE; BACTERIAL COUNT; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; COLONY FORMING UNIT; CONTROLLED STUDY; DIFFUSION; DNA EXTRACTION; DRUG EFFICACY; GENE; HAEMOPHILUS INFLUENZAE; INCUBATION TIME; INOCULATION; KLEBSIELLA PNEUMONIAE; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; PRIORITY JOURNAL; SIMULATION; SUSPENSION; TIME TO MAXIMUM PLASMA CONCENTRATION;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; DIFFUSION; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 79956294276     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01719-10     Document Type: Article

References (25)

1. Albritton, W. L., J. K. Setlow, and L. Slaney. 1982. Transfer of Haemophilus influenzae chromosomal genes by cell-to-cell contact. J. Bacteriol. 152:1066-1070. (Pubitemid 13190409)
2. Alou, L., et al. 2005. Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model. J. Antimicrob. Chemother. 55:209-213.
3. Ball, P., et al. 2002. Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J. Antimicrob. Chemother. 49:31-40.
4. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M7-A7. CLSI, Wayne, PA.
5. Dabernat, H., et al. 2002. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46:2208-2218.
6. García-Cobos, S., et al. 2008. Antibiotic resistance in Haemophilus influenzae decreased, except for beta-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in Spain from 1997 to 2007. Antimicrob. Agents Chemother. 52:2760-2766.
7. García-Cobos, S., et al. 2007. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob. Agents Chemother. 51:2564-2573.
8. González, N., et al. 2009. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different β-lactams: an in vitro pharmacodynamic approach. J. Antimicrob. Chemother. 63:1215-1222.
9. Goossens, H., M. Ferech, R. Vander Stichele, and M. Elseviers for the ESAC Project Group. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579-587.
10. Kim, I. S., et al. 2007. Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea. Antimicrob. Agents Chemother. 51:453-460.
11. Mulford, D., M. Mayer, and G. Witt. 2000. Effect of age and gender on the pharmacokinetics of cefditoren, abstr. 310. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother., Toronto, Ontario, Canada. American Society for Microbiology, Washington, DC.
12. Mulford, D., M. Mayer, and G. Witt. 2000. Effect of renal impairment on the pharmacokinetics of cefditoren, abstr. 311. Abstr. 40th Intersci. Conf. Antimicrob. Agents Chemother., Toronto, Ontario, Canada. American Society for Microbiology, Washington, DC.
13. Murchan, S., et al. 2003. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J. Clin. Microbiol. 41:1574-1585.
14. Murthy, T. F. 2005. Haemophilus influenzae, p. 2661-2669. In G. L. Mandell, R. G. Douglas, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th ed. Elsevier/Churchill Livingstone, Philadelphia, PA.
15. National Committee for Clinical Laboratory Standards. 1999. Methods for determining bactericidal activity of antimicrobial agents: approved guideline M26-A. NCCLS, Wayne, PA.
16. Pérez-Trallero, E., et al. 2005. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob. Agents Chemother. 49:1965-1972.
17. Sá-Leão, R., et al. 2008. High rates of transmission of and colonization by Streptococcus pneumoniae and Haemophilus influenzae within a day care center revealed in a longitudinal study. J. Clin. Microbiol. 46:225-234.
18. Sanbongi, Y., et al. 2006. Molecular evolution of beta-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Antimicrob. Agents Chemother. 50:2487-2492.
19. Scriver, S. R., et al. 1994. Determination of susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their β-lactamases. Antimicrob. Agents Chemother. 38:1678-1680.
20. Sevillano, D., et al. 2009. Genotypic versus phenotypic characterization, with respect to beta-lactam susceptibility, of Haemophilus influenzae isolates exhibiting decreased susceptibility to beta-lactam resistance markers. Antimicrob. Agents Chemother. 53:267-270.
21. Skaare, D., et al. 2010. Mutant ftsI genes in the emergence of penicillin-binding protein-mediated beta-lactam resistance in Haemophilus influenzae in Norway. Clin. Microbiol. Infect. 16:1117-1124.
22. Smith-Vaughan, H. C., et al. 1996. Carriage of multiple ribotypes of non-encapsulated Haemophilus influenzae in aboriginal infants with otitis media. Epidemiol. Infect. 116:177-183.
23. Takahata, S., et al. 2007. Horizontal gene transfer of ftsI, encoding penicillin-binding protein 3, in Haemophilus influenzae. Antimicrob. Agents Chemother. 51:1589-1595.
24. Takahata, S., Y. Kato, Y. Sanbongi, K. Maebashi, and T. Ida. 2008. Comparison of the efficacies of oral beta-lactams in selection of Haemophilus influenzae transformants with mutated ftsI genes. Antimicrob. Agents Chemother. 52:1880-1883.
25. Wellington, K., and M. P. Curran. 2004. Cefditoren pivoxil: a review of its use in the treatment of bacterial infections. Drugs 64:2597-2618.